NEW YORK (GenomeWeb News) – Agilent Technologies and WiCell said today they are teaming up to offer comparative genomic hybridization plus single nucleotide polymorphism microarray analysis services using the Agilent SurePrint G3 Human Genome CGH+SNP Microarray.

The microarray detects copy number changes by both SNP and CGH while simultaneously delivering copy-neutral change information such as loss or absence of heterozygosity, the companies said. They added that the assay maintains the high-resolution quality achieved with CGH-only microarrays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.